| 新调脂药应用分析 |
| |
| 引用本文： | 归成.新调脂药应用分析[J].中国医药技术经济与管理,2009,3(12):14-19. |
| |
| 作者姓名： | 归成 |
| |
| 作者单位： | 上海交通大学附属第一人民医院药剂科,上海,200080 |
| |
| 摘 要： | 了解上海市医院调脂药新品种的用药情况和变化趋势？方法分析2006-2008年上海市81家医院调脂药应用的新品种、数量、金额、DDDs和临床应用等情况，结果近年来上海医院调脂药新品种主要有胆固醇吸收抑制剂依折麦布、强效调脂药瑞舒伐他汀和老药新用普罗布考，其销售用量和金额呈快速上升趋势，为血脂异常的治疗增加有价值的新选择。结论调脂药新品种依折麦布、瑞舒伐他汀和普罗布考的市场前景引人注目。
|
| 关 键 词： | 新调脂药 销售金额 用药频度 临床评价 |
Analysis of new lipid modifying agents |
| |
| GUI Cheng.Analysis of new lipid modifying agents[J].Chinese Journal of Pharmacentical Technolgy Economics & Management,2009,3(12):14-19. |
| |
| Authors: | GUI Cheng |
| |
| Institution: | GUI Cheng( Department of Pharmacy, Affiliated First People＇s Hospital of Shanghai Jiaotong University, Shanghai 200080, China) |
| |
| Abstract: | Objective To investigate the use and trend of new lipid modifying agents in Shanghai hospitals Methods new lipid modifying agents used in 81 Shanghai hospitals were analyzed statistically in respect of amount of kinds, consumption sum, DDDs and clinical evaluation etc. Results During the period 2006-2008, the use of lipid modifying agents increased year by year. Leading the list in terms of consumption sum and DDDs were ezetimibe of Cholesterol absorption inhibition, rosuvastatin of the superactive modifying lipid agents and probucol of old drag new use. Conclusion The development trend of new lipid modifying agents is promising. |
| |
| Keywords: | New Lipid Modifying Agents Consumption Sum DDDs Clinical Evaluation |
| 本文献已被 维普 万方数据 等数据库收录！ |
